Compare Enveric Biosciences Inc (ENVB) vs SPDR Kensho Final Frontiers ETF (ROKT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs SPDR Kensho Final Frontiers ETF — how do they compare? Enveric Biosciences Inc trades at $1.48 (market cap $6.80M), while SPDR Kensho Final Frontiers ETF trades at $103.71 (market cap $170.14M). The key difference: SPDR Kensho Final Frontiers ETF is far larger — about 25× Enveric Biosciences Inc's market cap, and SPDR Kensho Final Frontiers ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and SPDR Kensho Final Frontiers ETF for 9 Days on average.
| ENVB | ROKT | |
|---|---|---|
Market Cap | $6.80M | $170.14M |
Volume | 64,867 | 12,298 |
Sector | Health | Sector/Thematic |
52-Week High | $10.80 | $136.68 |
52-Week Low | $1.27 | $72.93 |
Typical Hold Time | 14 Days | 9 Days |
Enterprise Value | -$1.49M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.45, down 3.01% today, with a bearish technical signal from moving averages. The company shows negative profitability metrics with ROE at -235.48% and ROA at -193.53%, though it has consistently beaten EPS estimates in recent quarters. Recent positive developments include new patent allowances and preclinical data supporting its non-hallucinogenic drug candidates.
The outlook remains speculative given the lack of revenue and negative cash flow from operations, offset by strong analyst buy ratings (75%). Key risks include clinical trial outcomes and funding needs, while catalysts hinge on regulatory progress and successful drug development in the competitive biotech space.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About SPDR Kensho Final Frontiers ETF
SPDR Kensho Final Frontiers ETF seeks exposure to companies supporting exploration of outer space and the deep sea. Its holdings include businesses involved in aerospace, defense, communications, research, and related technologies.
Read more on ROKT →
